It is blood pressure that drives the opening of small capillaries during angiogenesis. A team of researchers led by Prof. Holger Gerhardt of the MDC observed the process for the first time and published their findings in Nature Cell Biology. The scientists showed how the pressure exerted by the blood causes the membrane of endothelial cells to cave in and grow into the cell's body, until a continuous vessel forms. The cell itself directs the process with the help of the actomyosin filaments of its cytoskeleton. Until now, scientists did not have such a detailed view of how blood capillaries form, which is important in the contexts of embryonic development, cancer or diabetes.
Prof. Gerhardt's teams at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, the Berlin Institute of Health (BIH), and the German Center for Cardiovascular Research (DZHK) and the Vlaams Instituut voor Biotechnologie (VIB) in Leuven are studying the many different aspects of angiogenesis - the formation of new blood vessels from existing ones.
During "sprouting angiogenesis", new cells grow from the wall of existing nearby capillaries to make a new capillary loop. But until now, scientists did not know how the lumen forms, says Gerhardt.
Using a spinning-disk confocal microscope that provides high spatial and temporal resolution, the researchers studied zebrafish embryos in which the endothelial cell membranes had been genetically labeled with a fluorescing protein. They observed how the blood squeezes into the endothelial cell and, as it does so, the membrane of the new lumen grows. The cell actively controls the progression of the invagination. It pushes back smaller side branches and small bubbles by building actin fibers and then contracting them with the help of myosin filaments. This way the new capillary lumen only grows at the tip.
Capillaries grow whenever blood is required for new areas of tissue - during embryonic development or wound healing, for example. Angiogenesis is also of major importance in cancer. Growing tumors attempt to satisfy their ravenous hunger for energy and oxygen and let blood vessels sprout. "Blood vessels in tumors are not normal. They are leaky and often unable to control their diameter," says Gebala. The property of the lumen may also be relevant to other diseases, says Gerhardt: "If blood vessel formation depends so heavily on the hydrodynamics of the blood, what does this mean for physiological blood pressure?" For example, retinal blood vessels are destroyed in the eyes of diabetics, especially at sites affected by strong fluctuation in blood pressure.
Now the researchers are keen to find out how important the newly discovered mechanism of blood vessel is: "The next logical step is to study pathological situations," says Gebala.
Holger Gerhardt is research group leader at the MDC holds a "BIH-Professur" for Experimental Cardiovascular Research at the Charité - Universitätsmedizin Berlin, and a "DZHK-Professur".
A longer version of the article can be found at: https:/
Véronique Gebala1,3, Russell Collins1,3, Ilse Geudens2, Li-Kun Phng2,4, Holger Gerhardt1,2,3,5,6 (2016): „Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo." Nature Cell Biology. doi:10.1038/ncb3320
1 Vascular Biology Laboratory, Cancer Research UK London Research Institute, London, UK; 2 Vascular Patterning Laboratory, Vesalius Research Center, VIB, Department of Oncology, KU Leuven, Belgium; 3 Present address: Integrative Vascular Biology Laboratory, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; 4 Present address: Department of Cell Biology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; 5 DZHK (German Center for Cardiovascular Research), partner site Berlin 6, Berlin Institute of Health (BIH), Berlin, Germany Li-Kun Phng and Holger Gerhardt erqually contributed to the work.